National Institute for Cellular Biotechnology, Dublin City University, Dublin 9, Ireland; SSPC-SFI, Centre for Pharmaceuticals, Dublin City University, Dublin 9, Ireland.
National Institute for Bioprocessing Research & Training, A94 X099 Dublin, Ireland.
J Biol Chem. 2019 Dec 6;294(49):18756-18768. doi: 10.1074/jbc.RA119.011162. Epub 2019 Oct 30.
Polyamines have essential roles in cell proliferation, DNA replication, transcription, and translation processes, with intracellular depletion of putrescine, spermidine, and spermine resulting in cellular growth arrest and eventual death. Serum-free media for CHO-K1 cells require putrescine supplementation, because these cells lack the first enzyme of the polyamine production pathway, arginase. On the basis of this phenotype, we developed an arginase-based selection system. We transfected CHO-K1 cells with a bicistronic vector co-expressing GFP and arginase and selected cells in media devoid of l-ornithine and putrescine, resulting in mixed populations stably expressing GFP. Moreover, single clones in these selective media stably expressed GFP for a total of 42 generations. Using this polyamine starvation method, we next generated recombinant CHO-K1 cells co-expressing arginase and human erythropoietin (hEPO), which also displayed stable expression and healthy growth. The hEPO-expressing clones grew in commercial media, such as BalanCD and CHO-S serum-free media (SFM)-II, as well as in a defined serum-free, putrescine-containing medium for at least 9 passages (27 generations), with a minimal decrease in hEPO titer by the end of the culture. We observed a lack of arginase activity also in several CHO cell strains (CHO-DP12, CHO-S, and DUXB11) and other mammalian cell lines, including BHK21, suggesting broader utility of this selection system. In conclusion, we have established an easy-to-apply alternative selection system that effectively generates mammalian cell clones expressing biopharmaceutically relevant or other recombinant proteins without the need for any toxic selective agents. We propose that this system is applicable to mammalian cell lines that lack arginase activity.
多胺在细胞增殖、DNA 复制、转录和翻译过程中发挥着重要作用,细胞内精脒、亚精胺和精胺的耗尽会导致细胞生长停滞,最终死亡。用于 CHO-K1 细胞的无血清培养基需要补充精脒,因为这些细胞缺乏多胺生成途径的第一酶,精氨酸酶。基于这种表型,我们开发了一种基于精氨酸酶的选择系统。我们将共表达 GFP 和精氨酸酶的双顺反子载体转染 CHO-K1 细胞,并在缺乏 l-鸟氨酸和精脒的培养基中选择细胞,从而产生稳定表达 GFP 的混合细胞群。此外,在这些选择性培养基中的单个克隆总共稳定表达 GFP 达 42 代。使用这种多胺饥饿方法,我们接下来生成了共表达精氨酸酶和人红细胞生成素(hEPO)的重组 CHO-K1 细胞,这些细胞也表现出稳定表达和健康生长。表达 hEPO 的克隆在商业培养基中生长,如 BalanCD 和 CHO-S 无血清培养基(SFM)-II,以及在一种无血清、含精脒的定义培养基中生长至少 9 代(27 代),在培养结束时 hEPO 效价仅略有下降。我们还观察到在几种 CHO 细胞株(CHO-DP12、CHO-S 和 DUXB11)和其他哺乳动物细胞系,包括 BHK21 中也缺乏精氨酸酶活性,这表明这种选择系统具有更广泛的用途。总之,我们建立了一种易于应用的替代选择系统,可有效地生成表达生物制药相关或其他重组蛋白的哺乳动物细胞克隆,而无需任何有毒的选择性试剂。我们建议该系统适用于缺乏精氨酸酶活性的哺乳动物细胞系。